Nuwellis, Inc.

Contributing Author

Recent Articles by Nuwellis, Inc.

Sep-30	Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex NUWE GlobeNewswire
Sep-18	Nuwellis Receives New US Patent Reinforcing Vivian Pediatric Device Focused on Safer, More Precise Ultrafiltration NUWE GlobeNewswire
Sep-17	Nuwellis, Inc. Participates in a Virtual Investor "What This Means" Segment NUWE GlobeNewswire
Sep-09	Nuwellis' Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio NUWE GlobeNewswire
Sep-04	Nuwellis Introduces New 24-Hour Aquadex Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management NUWE GlobeNewswire
Aug-21	Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter NUWE GlobeNewswire
Aug-19	Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company NUWE GlobeNewswire
Aug-15	Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech NUWE GlobeNewswire
Aug-14	Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights NUWE GlobeNewswire
Aug-07	Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus NUWE GlobeNewswire
Aug-06	Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025 NUWE GlobeNewswire
Aug-05	Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow System Under New CMS Code NUWE GlobeNewswire
Aug-04	Nuwellis Stockholders Approve All Proposals at Special Meeting NUWE GlobeNewswire
Jul-23	Nuwellis Participates in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference NUWE GlobeNewswire
Jul-23	Nuwellis Regains Compliance with Nasdaq Listing Requirements NUWE GlobeNewswire
Jul-22	Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025 NUWE GlobeNewswire
Jul-17	Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care NUWE GlobeNewswire
Jul-15	Nuwellis Secures New U.S. Patent, Strengthening Its Position as a Leader in Fluid Management Innovation NUWE GlobeNewswire
Jul-02	Nuwellis Appoints John Erb as Chief Executive Officer NUWE GlobeNewswire
Jun-10	Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option NUWE GlobeNewswire
Jun-09	Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offering NUWE GlobeNewswire
May-13	Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights NUWE GlobeNewswire
May-12	Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency NUWE GlobeNewswire
May-08	Nuwellis Expands Aquadex for Pediatric Fluid Management to Two New Hospital Systems NUWE GlobeNewswire

Nuwellis, Inc.

Recent Articles by Nuwellis, Inc.

Upgrade your FINVIZ experience